Operating cash flow decreased 32.4%
Operating cash flow changed -32.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$62.1M→$42.0M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →DOCS financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income decreased 38.3%
Operating income changed -38.3% from the comparable as-filed period.
$54.5M→$33.6M2 prior comparisons
Operating margin moved 1588 bp lower
Operating margin changed -1588 basis points from the comparable as-filed period.
37.36%→21.48%2 prior comparisons
Net income decreased 54.4%
Net income changed -54.4% from the comparable as-filed period.
$53.3M→$24.3M2 prior comparisons
Gross margin moved 430 bp lower
Gross margin changed -430 basis points from the comparable as-filed period.
89.18%→84.87%2 prior comparisons
Cash & equivalents increased 99.3%
Cash & equivalents changed +99.3% from the comparable as-filed period.
$137.3M→$273.6M3 prior comparisons
Research & development increased 43.6%
Research & development changed +43.6% from the comparable as-filed period.
$26.8M→$38.5M2 prior comparisons
SBC / revenue moved 848 bp higher
SBC / revenue changed +848 basis points from the comparable as-filed period.
14.98%→23.47%2 prior comparisons
Stock-based compensation increased 68.1%
Stock-based compensation changed +68.1% from the comparable as-filed period.
$21.9M→$36.8M2 prior comparisons
Trade receivables increased 25.4%
Trade receivables changed +25.4% from the comparable as-filed period.
$141.7M→$177.6M3 prior comparisons
Operating cash-flow margin moved 1575 bp lower
Operating cash-flow margin changed -1575 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
42.56%→26.81%2 prior comparisons
Revenue increased 7.3%
Revenue changed +7.3% from the comparable as-filed period.
$145.9M→$156.6M2 prior comparisons
Operating cash flow / net income increased 48.3%
Operating cash flow / net income changed +48.3% from the comparable as-filed period.
1.16→1.732 prior comparisons
R&D / revenue moved 620 bp higher
R&D / revenue changed +620 basis points from the comparable as-filed period.
18.37%→24.57%2 prior comparisons
Receivables / revenue moved 1629 bp higher
Receivables / revenue changed +1629 basis points from the comparable as-filed period.
97.09%→113.38%2 prior comparisons
Working capital decreased 12.7%
Working capital changed -12.7% from the comparable as-filed period.
$874.3M→$763.6M3 prior comparisons
Current assets decreased 11.6%
Current assets changed -11.6% from the comparable as-filed period.
$1.0B→$914.0M3 prior comparisons
Stockholders' equity decreased 10.7%
Stockholders' equity changed -10.7% from the comparable as-filed period.
$1.0B→$916.1M2 prior comparisons
Total assets decreased 10.0%
Total assets changed -10.0% from the comparable as-filed period.
$1.2B→$1.1B3 prior comparisons
Working capital / assets moved 214 bp lower
Working capital / assets changed -214 basis points from the comparable as-filed period.
72.59%→70.45%3 prior comparisons
Current liabilities decreased 6.0%
Current liabilities changed -6.0% from the comparable as-filed period.
$159.9M→$150.4M3 prior comparisons
Gross profit increased 2.2%
Gross profit changed +2.2% from the comparable as-filed period.
$130.1M→$132.9M2 prior comparisons
Current ratio decreased 6.0%
Current ratio changed -6.0% from the comparable as-filed period.
6.47→6.083 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.